In-field recurrences in relapsed/refractory (R/R) B-cell non-Hodgkin lymphoma (NHL) bridged with radiation prior to CD19 chimeric antigen receptor T-cell therapy (CART).

Authors

null

Omran Saifi

Mayo Clinic Department of Radiation Oncology, Jacksonville, FL

Omran Saifi , William Breen , Scott Lester , William G. Rule , Brad J. Stish , Allison Claire Rosenthal , Javier Munoz , Yi Lin , Nabila Nora Bennani , Jonas Paludo , Arushi Khurana , Jose Caetano Villasboas , Patrick B. Johnston , Stephen M. Ansell , Madiha Iqbal , Muhamad Alhaj Moustafa , Hemant S. Murthy , Mohamed Kharfan-Dabaja , Bradford Hoppe , Jennifer Peterson

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia

Track

Hematologic Malignancies

Sub Track

Non-Hodgkin Lymphoma

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 7556)

DOI

10.1200/JCO.2022.40.16_suppl.7556

Abstract #

7556

Poster Bd #

209

Abstract Disclosures